IL164092A0 - The use of devazepide as analgesic agent - Google Patents

The use of devazepide as analgesic agent

Info

Publication number
IL164092A0
IL164092A0 IL16409203A IL16409203A IL164092A0 IL 164092 A0 IL164092 A0 IL 164092A0 IL 16409203 A IL16409203 A IL 16409203A IL 16409203 A IL16409203 A IL 16409203A IL 164092 A0 IL164092 A0 IL 164092A0
Authority
IL
Israel
Prior art keywords
devazepide
analgesic agent
analgesically effective
administration
manufacture
Prior art date
Application number
IL16409203A
Other languages
English (en)
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of IL164092A0 publication Critical patent/IL164092A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16409203A 2002-04-09 2003-04-09 The use of devazepide as analgesic agent IL164092A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208129.7A GB0208129D0 (en) 2002-04-09 2002-04-09 Method of treatment
PCT/GB2003/001514 WO2003086409A1 (en) 2002-04-09 2003-04-09 The use of devazepide as analgesic agent

Publications (1)

Publication Number Publication Date
IL164092A0 true IL164092A0 (en) 2005-12-18

Family

ID=9934506

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16409203A IL164092A0 (en) 2002-04-09 2003-04-09 The use of devazepide as analgesic agent

Country Status (13)

Country Link
EP (1) EP1492540B1 (de)
JP (1) JP2005529106A (de)
AT (1) ATE375796T1 (de)
AU (1) AU2003227858A1 (de)
BR (1) BR0309139A (de)
CA (1) CA2481272A1 (de)
DE (1) DE60316927T2 (de)
GB (1) GB0208129D0 (de)
IL (1) IL164092A0 (de)
MX (1) MXPA04009885A (de)
NO (1) NO20043774L (de)
PL (1) PL372986A1 (de)
WO (1) WO2003086409A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325957D0 (en) * 2003-11-06 2003-12-10 Arakis Ltd The treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
JP2005529106A (ja) 2005-09-29
GB0208129D0 (en) 2002-05-22
DE60316927D1 (de) 2007-11-29
NO20043774L (no) 2005-01-06
AU2003227858A1 (en) 2003-10-27
ATE375796T1 (de) 2007-11-15
MXPA04009885A (es) 2004-12-07
PL372986A1 (en) 2005-08-08
BR0309139A (pt) 2005-02-01
EP1492540B1 (de) 2007-10-17
DE60316927T2 (de) 2008-07-24
WO2003086409A1 (en) 2003-10-23
EP1492540A1 (de) 2005-01-05
CA2481272A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
WO2004056305A3 (en) Administration of capsaicinoids
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
AU2003297621A8 (en) Medical devices for delivery of therapeutic agents
IL155781A0 (en) Effective antitumor treatments
EP1514105A4 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
EP1663377A4 (de) Therapeutisches medizinisches gerät, abgabe und anwendungsverfahren
GB0020504D0 (en) Therapeutic method
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
SE9902597D0 (sv) New use
GEP201606538B (en) Preoperative treatment of post operative pain
AU2001236529A1 (en) Combination therapy for cancer
IL164092A0 (en) The use of devazepide as analgesic agent
AU4258601A (en) Divided dose therapies with vascular damaging activity
IL159770A0 (en) Calcium salts with cytotoxic activity
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon